A Study of Irinotecan With Dabrafenib Plus Trametinib and Anti-EGFR in the Second Line of Therapy in People With Metastatic Colorectal Cancer
Clinical trial NCT06967155 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06967155
- Sponsor
- Blokhin's Russian Cancer Research Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-01
- Primary completion
- 2027-11-10
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.